2023 Fall Conference | L3 - Turning Conflict into Collaboration: Using Neuroscience for Programs and Organizations to Thrive

Date Friday 10/27/23

Time 01:00 PM - 02:30 PM PDT Add To Calendar

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ezgi Tiryaki, MD, FAAN

Topic(s) Leadership

Learning Objectives Participants should learn about a common stumbling block to working in teams: conflict. Participants should learn about a neuroscience-based tool to work through, rather than avoid, conflict. The SCARF model involves five domains of human social experience: Status, Certainty, Autonomy, Relatedness and Fairness. Status is about relative importance to others. Certainty is about the ability to predict the future. Autonomy provides a sense of control. Relatedness is a sense of safety with others. Fairness is a perception of fair exchanges between people. Participants should be able to apply a neuroscience-based model to organizational conflict, reflect on procedures and practices that trigger a threat response in organizations, and develop action steps that help reduce social threat and maximize rewards for improved organizational leadership.

This program is supported in part by an educational grant from Alnylam Pharmaceuticals, Inc.
The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

CME Available 1.50 CME credits

Core Competencies Interpersonal and Communication Skills, Professionalism

Recommended Audience Fellow, Resident, Other, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Case-based, Interactive, Audience Participation, Small Group

Event Timeline
01:00 PM - 01:10 PM PDT	Introduction	Introduction & Icebreaker Jeffrey C. McClean II, MD, FAAN
01:10 PM - 01:20 PM PDT	Speaker	Introduction to SCARF Ezgi Tiryaki, MD, FAAN
01:20 PM - 01:30 PM PDT	Discussion	Organization Level Case Study Jeffrey C. McClean II, MD, FAAN
01:30 PM - 02:05 PM PDT	Discussion	Case Study Group Activity Ezgi Tiryaki, MD, FAAN
02:05 PM - 02:25 PM PDT	Discussion	Discussion & Group Debrief Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN
02:25 PM - 02:30 PM PDT	Speaker	Summary & Closing Remarks Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN

Faculty Disclosures
Ezgi Tiryaki, MD, FAAN	Dr. Tiryaki has or had stock in HITIT Leadership Coaching.Dr. Tiryaki has a non-compensated relationship as a Professor of Neurology with University of Minnesota that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Clinic Director of a Center of Excellence with The ALS Association that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Volunteer Clinical Neurologist at ALS Clinic with Minneapolis VA Healthcare System that is relevant to AAN interests or activities.
Jeffrey C. McClean II, MD, FAAN	Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with American Academy of Neurology.
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN	Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wellcome Trust. The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from Rosetrees Trust. The institution of Dr. De Luca has received research support from Strategic Innovation Fund, Oxford University. The institution of Dr. De Luca has received research support from Agence National de la Recherche. Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Editorial board member with Continuum (AAN) that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Editorial board member with Frontiers in Neurology that is relevant to AAN interests or activities.